Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huayi Isotopes is a leading global manufacturer and supplier specializing in stable isotopes and radiopharmaceutical precursors for medical imaging and therapy. The company is recognized as one of the world's largest producers of Oxygen-18 water, a critical raw material for the synthesis of [18F]FDG used in PET imaging. Beyond isotopes, Huayi provides a comprehensive portfolio of high-purity precursors and reference standards for oncology, neurology, and cardiology applications, including agents targeting PSMA and somatostatin receptors. Their state-of-the-art facilities operate under strict GMP standards to support pharmaceutical companies and research institutions worldwide. By providing essential building blocks for molecular imaging, Huayi Isotopes plays a pivotal role in the global radiopharmaceutical supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huayi Isotopes.